BIIB logo

Biogen Inc (BIIB)

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral scle...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

公司簡介

股票程式碼
BIIB
ISIN程式碼
US09062X1037
貨幣
US Dollar (USD)
IPO日期
1991-09-16

聯絡資訊

公司地址
225 Binney Street, Cambridge, MA, United States, 02142
聯絡電話
617 679 2000
公司網站
https://www.biogen.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
5.21%
EBITDA
$999,999.99
收入(TTM)
$999,999.99